Page last updated: 2024-10-28

hydroxychloroquine and Benign Paroxysmal Peritonitis

hydroxychloroquine has been researched along with Benign Paroxysmal Peritonitis in 6 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Endo, Y2
Koga, T2
Umeda, M1
Furukawa, K1
Sasaki, D1
Yanagihara, K1
Kawakami, A2
Batu, ED1
Ozen, S1
Kiyani, A1
Parperis, K2
Erten, S1
Taskaldiran, I1
Yakut, ZI1
Basaran, O1
Aydın, F1
Celikel, BA1
Uncu, N1
Cakar, N1

Reviews

1 review available for hydroxychloroquine and Benign Paroxysmal Peritonitis

ArticleYear
Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature.
    Renal failure, 2013, Volume: 35, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cytoskeletal Pr

2013

Other Studies

5 other studies available for hydroxychloroquine and Benign Paroxysmal Peritonitis

ArticleYear
Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2020, 04-01, Volume: 59, Issue:4

    Topics: Adult; Antirheumatic Agents; Asian People; Colchicine; Cytokines; Familial Mediterranean Fever; Fema

2020
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2020, 12-01, Volume: 59, Issue:12

    Topics: Familial Mediterranean Fever; Humans; Hydroxychloroquine; Japan; Lupus Erythematosus, Systemic; Pyri

2020
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply.
    Rheumatology (Oxford, England), 2020, 12-01, Volume: 59, Issue:12

    Topics: Familial Mediterranean Fever; Humans; Hydroxychloroquine; Japan; Lupus Erythematosus, Systemic; Pyri

2020
Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune Disease With an Autoinflammatory Disease.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2018, Volume: 24, Issue:2

    Topics: Adult; Antirheumatic Agents; Colchicine; Familial Mediterranean Fever; Female; Humans; Hydroxychloro

2018
Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient.
    Lupus, 2016, Volume: 25, Issue:9

    Topics: Adolescent; Colchicine; Cyclophosphamide; Familial Mediterranean Fever; Female; Humans; Hydroxychlor

2016